Sign In

Adel Malek

Chief of Neurovascular Surgery at Tufts Medical Center

Dr. Adel Malek is a prominent neurosurgeon and medical innovator who was appointed as the Chief Medical Officer of CereVasc, Inc. in March 2023.1 He brings a wealth of experience and expertise to this role, making him a valuable addition to the company's leadership team.

Professional Background

Dr. Malek holds several distinguished positions in the field of neurosurgery:

  • Chief of Neurovascular Surgery at Tufts Medical Center
  • Director of the Cerebrovascular and Endovascular Division in the Department of Neurosurgery at Tufts Medical Center
  • Professor of Neurosurgery at Tufts University School of Medicine12

Education and Training

Dr. Malek's educational background is impressive:

  • Medical degree from Harvard Medical School
  • Doctorate in medical engineering and Physics from the Massachusetts Institute of Technology
  • Neurosurgical training at Brigham and Women's/Children's Hospital Boston
  • Neurointerventional radiology fellowship at the University of California, San Francisco2

Expertise and Research

Dr. Malek is board-certified in neurosurgery and specializes in:

  • Multi-modal and minimally invasive treatment of brain aneurysms
  • Treatment of arteriovenous malformations (AVMs) and dural arteriovenous fistulas (DAVFs)
  • Research on cellular and hemodynamic mechanisms in brain aneurysms and AVMs
  • Development of endovascular technologies2

Role at CereVasc

As the Chief Medical Officer and co-founder of CereVasc, Dr. Malek plays a crucial role in the company's mission to develop novel, minimally invasive treatments for neurological diseases.12 He is a co-inventor of the eShunt endovascular device, which is designed to treat communicating hydrocephalus.1

Dr. Malek expressed his enthusiasm for his role at CereVasc, stating that he is "Grateful to be part of this exciting journey to provide a less invasive endovascular treatment approach to hydrocephalus for our patients!"3

Highlights

Jun 5 · cerevasc.com
eShunt® Device Endovascular Shunt | CereVasc Team
eShunt® Device Endovascular Shunt | CereVasc Team
Cancer-killing gel, minimally-invasive brain shunts: Here are recent startups spun out of area hospitals - Boston ... - The Business Journals
Cancer-killing gel, minimally-invasive brain shunts: Here are recent startups spun out of area hospi
Nov 6 · cerevasc.com
CereVasc Appoints Dr. Adel Malek Chief Medical Officer
Cerevasc appoints Adel Malek as its new chief medical officer
Cerevasc appoints Adel Malek as its new chief medical officer
Mar 28 · prnewswire.com
CereVasc Appoints Dr. Adel Malek Chief Medical Officer
Mar 28 · evtoday.com
CereVasc Appoints Dr. Adel Malek Chief Medical Officer
CereVasc Appoints Dr. Adel Malek Chief Medical Officer
Mar 28 · massdevice.com
Cerevasc has a new chief medical officer - MassDevice
Cerevasc has a new chief medical officer - MassDevice
Nov 26 · The Boston Globe
Danger for Will Robinson, good times for everyone else in ... - The Boston Globe
Danger for Will Robinson, good times for everyone else in ... - The Boston Globe

Related Questions

What is the eShunt endovascular device used for?
What are Dr. Malek's main research interests?
How did Dr. Malek contribute to the development of the eShunt device?
What is the role of the Cerebrovascular and Endovascular Division at Tufts Medical Center?
What is Dr. Malek's educational background?
Adel Malek
Adel Malek, photo 1
Adel Malek, photo 2
Add to my network

Location

Boston, Massachusetts, United States